Researchers collated and analyzed 12 studies comprising more than 17 years’ worth of case-control experiments aimed at elucidating site-specific cancer outcomes of legume consumption.
Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update – Biotech Investments
Issuer: Immunic AG / Key word(s): Miscellaneous 31.10.2024 / 11:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic, Inc. to